Deleterious BRCA2 sequence variants are over-represented in cases of T-cell Non-Hodgkins lymphoma (NHL) or CLL [see Additional file 1], consistent with a role for BRCA2 in preventing these diseases. The gene discussed is BRCA2; the disease is non-Hodgkin lymphoma.